Ma et al. [24] reported that the over-expression of MALAT1 in glioma tissues was positively correlated with grade and tumour size, suggesting that MALAT1 may serve as an authentic prognostic biomarker for patients with glioma. Here, MALAT1 is linked to neoplasm.